Urea breath test for Helicobacter pylori detection: present status
- PMID: 15912972
Urea breath test for Helicobacter pylori detection: present status
Abstract
Helicobacter pylori (H. pylori) is the commonest bacterial pathogen found worldwide and more than half the world population aged 40 years and above is colonized with it. The infection rate is >95 % in some African countries. In 1994, the International Agency for Research on cancer classified H. pylori as a class I carcinogen in humans. It causes chronic active gastritis, duodenal and gastric ulcer and gastric malignancy, and is thought to be associated with coronary artery disease, cerebral stroke, vitamin B12 and iron-deficiency anaemia, etc. Therefore, non-invasive test-and-treatment strategies are widely recommended in primary care settings. Conventionally, H. pylori infection can be diagnosed by invasive techniques using an upper gastrointestinal endoscope for obtaining multiple biopsies from different sites of the stomach for RUT, culture, histological examination, polymerase chain reaction (PCR), etc. and by non-invasive tests such as Urea breath test (UBT), stool antigen test and blood serology. At present, 13/14C-UBT is considered the test of choice for confirmation of H. pylori infection. The UBT is based on the principle, that isotopically labelled urea ingested by an H. pylori--infected patient is rapidly hydrolysed by the microbial urease. The released 13/14CO2 is absorbed across the mucous layer to the gastric mucosa and hence, excreted via the systemic circulation in the breath which is collected and measured. The non-hydrolysed urea is excreted completely in the urine within 3-4 days. 13C-UBT being non-radioactive, 13C-UBT can be used in pregnant women and children, and a user's license is not required. There is still no standard protocol accepted and followed internationally for this test. Although the methods are almost similar, various laboratories/clinics use variable tracer doses, test meals, timings and methods for breath collection, and different cut-off values, which make formal validation studies necessary. This review describes the present status of the UBT and its application in the detection of H. pylori infection.
Similar articles
-
Validation of 13C-urea breathtest for the diagnosis of Helicobacter pylori infection in the Singapore population.Singapore Med J. 2002 Aug;43(8):408-11. Singapore Med J. 2002. PMID: 12507026 Clinical Trial.
-
Quantitative correlation of Helicobacter pylori stool antigen (HpSA) test with 13C-urea breath test (13C-UBT) by the updated Sydney grading system of gastritis.Hepatogastroenterology. 2002 Mar-Apr;49(44):576-9. Hepatogastroenterology. 2002. PMID: 11995501
-
[Diagnosis of Helicobacter pylori with the 13C-labeled urea breath test: study methodology].Cas Lek Cesk. 2000 Dec 6;139(24):776-8. Cas Lek Cesk. 2000. PMID: 11262917 Czech.
-
Clinical studies of 13C-urea breath test in Japan.J Gastroenterol. 1998;33 Suppl 10:36-9. J Gastroenterol. 1998. PMID: 9840015 Review.
-
Urea breath tests in the management of Helicobacter pylori infection.Gut. 1998 Jul;43 Suppl 1(Suppl 1):S47-50. doi: 10.1136/gut.43.2008.s47. Gut. 1998. PMID: 9764040 Free PMC article. Review.
Cited by
-
Association of Helicobacter Pylori in Carcinoma Stomach at Maharaja Krishna Chandra Gajapat Medical College: A Prospective Study.Cureus. 2022 Oct 26;14(10):e30709. doi: 10.7759/cureus.30709. eCollection 2022 Oct. Cureus. 2022. PMID: 36439609 Free PMC article.
-
Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients.World J Gastroenterol. 2007 Feb 14;13(6):925-9. doi: 10.3748/wjg.v13.i6.925. World J Gastroenterol. 2007. PMID: 17352025 Free PMC article.
-
Helicobacter pylori infection in children: an overview of diagnostic methods.Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1035-1045. doi: 10.1007/s10096-019-03502-5. Epub 2019 Feb 7. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30734129 Review.
-
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.Clin Microbiol Rev. 2022 Sep 21;35(3):e0025821. doi: 10.1128/cmr.00258-21. Epub 2022 Apr 11. Clin Microbiol Rev. 2022. PMID: 35404105 Free PMC article. Review.
-
An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer.Lung Cancer (Auckl). 2021 Aug 16;12:81-92. doi: 10.2147/LCTT.S320493. eCollection 2021. Lung Cancer (Auckl). 2021. PMID: 34429674 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical